| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
|
Hughes, Graham R V
|
|
2014
|
23 |
12 |
p. 1225-1225
|
artikel
|
| 2 |
Antibodies to phosphatidylserine/prothrombin complex and the antiphospholipid syndrome
|
Sciascia, S
|
|
2014
|
23 |
12 |
p. 1309-1312
|
artikel
|
| 3 |
Antiphospholipid antibodies and infertility
|
Chighizola, CB
|
|
2014
|
23 |
12 |
p. 1232-1238
|
artikel
|
| 4 |
Antiphospholipid scoring: significance in diagnosis and prognosis
|
Oku, K
|
|
2014
|
23 |
12 |
p. 1269-1272
|
artikel
|
| 5 |
Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation
|
Tebo, AE
|
|
2014
|
23 |
12 |
p. 1313-1316
|
artikel
|
| 6 |
Assisted reproductive technology in SLE and APS
|
Levine, AB
|
|
2014
|
23 |
12 |
p. 1239-1241
|
artikel
|
| 7 |
Autoantibody profiling in APS
|
Roggenbuck, D
|
|
2014
|
23 |
12 |
p. 1262-1264
|
artikel
|
| 8 |
Autoimmunity, phospholipid-reacting antibodies and malaria immunity
|
Gomes, LR
|
|
2014
|
23 |
12 |
p. 1295-1298
|
artikel
|
| 9 |
Cardiovascular disease in the antiphospholipid syndrome
|
Amaya-Amaya, Jenny
|
|
2014
|
23 |
12 |
p. 1288-1291
|
artikel
|
| 10 |
Catastrophic antiphospholipid syndrome: task force report summary
|
Cervera, R
|
|
2014
|
23 |
12 |
p. 1283-1285
|
artikel
|
| 11 |
Children born to SLE and APS mothers
|
Nalli, C
|
|
2014
|
23 |
12 |
p. 1246-1248
|
artikel
|
| 12 |
Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies
|
Romay-Penabad, Z
|
|
2014
|
23 |
12 |
p. 1324-1326
|
artikel
|
| 13 |
Contraception in patients with systemic lupus erythematosus and antiphospholipid syndrome
|
Sammaritano, LR
|
|
2014
|
23 |
12 |
p. 1242-1245
|
artikel
|
| 14 |
Domain I: the hidden face of antiphospholipid syndrome
|
Pericleous, C
|
|
2014
|
23 |
12 |
p. 1320-1323
|
artikel
|
| 15 |
Identification and treatment of APS renal involvement
|
Tektonidou, MG
|
|
2014
|
23 |
12 |
p. 1276-1278
|
artikel
|
| 16 |
Immunologic derangement preceding clinical autoimmunity
|
Dellavance, A
|
|
2014
|
23 |
12 |
p. 1305-1308
|
artikel
|
| 17 |
International standards for IgG and IgM anti-β2glycoprotein antibody measurement
|
Willis, R
|
|
2014
|
23 |
12 |
p. 1317-1319
|
artikel
|
| 18 |
Long-term persistence of anti-β2 glycoprotein I in treated leprosy patients
|
Ribeiro, SLE
|
|
2014
|
23 |
12 |
p. 1249-1251
|
artikel
|
| 19 |
Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation
|
Forastiero, R
|
|
2014
|
23 |
12 |
p. 1252-1254
|
artikel
|
| 20 |
My contribution, my dream – a look at the future of APS
|
Koike, T
|
|
2014
|
23 |
12 |
p. 1332-1334
|
artikel
|
| 21 |
New oral anticoagulants in thrombotic antiphospholipid syndrome
|
Chighizola, CB
|
|
2014
|
23 |
12 |
p. 1279-1282
|
artikel
|
| 22 |
Patient–health care provider relationship: how can it impact on APS (Hughes’ syndrome) adherence to treatment?
|
Levy, RA
|
|
2014
|
23 |
12 |
p. 1265-1268
|
artikel
|
| 23 |
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality
|
Dall’Ara, F
|
|
2014
|
23 |
12 |
p. 1255-1258
|
artikel
|
| 24 |
Pre-eclampsia as a manifestation of antiphospholipid syndrome: assessing the current status
|
Gibbins, KJ
|
|
2014
|
23 |
12 |
p. 1229-1231
|
artikel
|
| 25 |
Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand?
|
Wong, LF
|
|
2014
|
23 |
12 |
p. 1226-1228
|
artikel
|
| 26 |
The autoimmune tautology with a focus on antiphospholipid syndrome
|
Franco, J-S
|
|
2014
|
23 |
12 |
p. 1273-1275
|
artikel
|
| 27 |
The dual role of innate immunity in antiphospholipid syndrome and systemic lupus erythematosus
|
Salem, D
|
|
2014
|
23 |
12 |
p. 1327-1331
|
artikel
|
| 28 |
The use of angiogenic and antiangiogenic factors in the differential diagnosis of pre-eclampsia, antiphospholipid syndrome nephropathy and lupus nephritis
|
de Jesus, GR
|
|
2014
|
23 |
12 |
p. 1299-1301
|
artikel
|
| 29 |
Thrombotic risk assessment in APS: the Global APS Score (GAPSS)
|
Sciascia, S
|
|
2014
|
23 |
12 |
p. 1286-1287
|
artikel
|
| 30 |
Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells
|
Borghi, MO
|
|
2014
|
23 |
12 |
p. 1302-1304
|
artikel
|
| 31 |
Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome
|
de Abreu, M Mendes
|
|
2014
|
23 |
12 |
p. 1292-1294
|
artikel
|
| 32 |
What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?
|
Amigo, M-C
|
|
2014
|
23 |
12 |
p. 1259-1261
|
artikel
|
Tijdschrift beschrijving